Corrigendum to "COV is a readily available quantitative indicator of metabolic heterogeneity for predicting survival of patients with early and locally advanced NSCLC manifesting as central lung cancer" [Eur. J. Radiol. 132 (2020) 109338]. Issue 133 (December 2020)